Murali Prahalad
Director/Board Member en MARAVAI LIFESCIENCES HOLDINGS, INC. .
Fortuna: 388 615 $ al 31/03/2024
Perfil
Murali K.
Prahalad is currently the President & Chief Executive Officer at Iridia, Inc. and the Director at Epic Sciences, Inc. He is also a Director at Maravai Life Sciences, Inc. and Maravai Lifesciences Holdings, Inc. Previously, he held the position of Vice President-Business Development at Sequenom, Inc. and Vice President-Corporate Strategy at Life Technologies Corp.
from 2012 to 2013.
Dr. Prahalad received his graduate and doctorate degrees from Harvard University and his undergraduate degree from the University of Michigan.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/07/2023 | 44 823 ( 0.03% ) | 388 615 $ | 31/03/2024 |
Cargos activos de Murali Prahalad
| Empresas | Cargo | Inicio |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Director/Board Member | 01/08/2016 |
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Director/Board Member | 01/04/2019 |
Iridia, Inc.
 Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Chief Executive Officer | 01/11/2019 |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Director/Board Member | - |
Antiguos cargos conocidos de Murali Prahalad.
| Empresas | Cargo | Fin |
|---|---|---|
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01/01/2013 |
| SEQUENOM, INC. | Corporate Officer/Principal | - |
Formación de Murali Prahalad.
| Harvard University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
Iridia, Inc.
Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Commercial Services |
| Maravai Lifesciences Holdings, Inc. |
- Bolsa de valores
- Insiders
- Murali Prahalad
